Hormone therapy after menopause questioned for heart benefits
A study questions heart health benefits of hormone replacement therapy HRT for postmenopausal women and suggests doctors may rethink prescribing guidelines. Researchers note short term risk rises after a heart event while longer use shows unclear risk reductions possibly due to healthier lifestyles.
MENTIONED IN THIS ARTICLE
Philadelphia
JoAnn E. Manson
Nurses
Annals of Internal Medicine
Manson
Brigham and Women’s Hospital
Boston
Nicca Goldberg
Lenox Hill Hospital
New York City
Beverly Enterprises settles 1.2 million suit over racial bias
Beverly Enterprises Inc. agreed to pay 1.2 million to nine former workers who alleged discrimination against black employees at Bridgeton Nursing Center in Missouri. The EEOC says a personnel worker will be disciplined and the firm has updated management and reporting policies. The settlement awaits federal court approval.
MENTIONED IN THIS ARTICLE
ST. Louis
Beverly Enterprises Inc
U.S. Equal Employment Opportunity Commission
Beverly
Bridgeton Nursing Center
Denella Marlay
Bridgeton
Dan Springer
Beverly Enterprises
Fort Smith, Ark
District of Columbia
F ‘Deral District Court
Marlay
Felix Miller
EEOC
Springer
Subway settles hepatitis lawsuit over 1999 outbreak
An 8-year-old boy who contracted hepatitis A after eating at a Subway in September 1999 received a 10 million settlement. The agreement covers Christian Decker and his parents, with 6 million from Doctor Association and 2 million each from Subway Northwest and store owners Thomas Sandstedt and Lisa Nguyen.
MENTIONED IN THIS ARTICLE
Seattle
Christian Decker
Christian
Doctor Association
Subway
Subway Northwest
Thomas Sandstedt
Lisa
Higher-Dose Short Course Antibiotics Could Curb Resistance
Government study of children suggests that higher-dose, five-day antibiotic courses may equal standard ten-day penicillin treatments in treating ear infections pneumonia and meningitis. Widespread resistance blamed partly on antibiotic overuse.
MENTIONED IN THIS ARTICLE
Chicago
First all internal artificial heart implanted in patient
Surgeons at Jewish Hospital Louisville implanted the Abiomed AbioCor device in a terminally ill patient, aiming to extend life by about 60 days. The trial involves five hospitals including Brigham & Women’s, MGH, Hahnemann, Texas Heart Institute, and UCLA.
MENTIONED IN THIS ARTICLE
Louisville, Ky
University of Louisville
Jewish Hospital
Laman Gray
Robert Dowling
Abiomed Inc
Danvers
Mass
David Faxon
American Heart Association
David M. Lederman
Abiomed
Food and Drug Administration
Lederman
Barney Clark
Seattle Area
William Schroeder
Jasper
Ind
Thomas Gaidosh
Sutersville
Robert Jarvik
Brigham & Women's
Massachusetts General
Boston
Hahnemann University Hospital
Philadelphia
Texas Heart Institute
Houston
Ucla Medical Center
Los Angeles
AP Photo
Robert T. W. King
William Bolt
Louisville
Also Mentioned on This Page
Ray Randle
Juan Camacho
el Paso